发明名称 |
TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS |
摘要 |
The present invention relates to the treatment of EGFR-mediated disease, particularly cancer by inhibiting or blocking EGFR and src in combination or simultaneously. The invention relates to treatment, prevention, or modulation of cancer, particularly EGFR- mediated disease, with one or more EGFR modulator and src inhibitor in combination. The invention further relates to the treatment of cancer with anti-EGFR antibodies and src inhibitors. Methods and compositions for treatment of cancer with the antibody anti- EGFR mAb806 in combination or series with a src inhibitor or src inhibitors are described. |
申请公布号 |
CA2680854(C) |
申请公布日期 |
2017.02.14 |
申请号 |
CA20082680854 |
申请日期 |
2008.03.14 |
申请人 |
LUDWIG INSTITUTE FOR CANCER RESEARCH |
发明人 |
CAVENEE, WEBSTER;FURNARI, FRANK;JOHNS, TERRANCE GRANT;SCOTT, ANDREW |
分类号 |
A61K39/395;A61K31/506;A61K31/517;A61K31/519;C07K16/28;C12N9/10 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|